Vanguard Group
CEMI

Vanguard Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Vanguard Group’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,561,470
Closed -$690K – 4648
2023
Q1 		$690K Hold
1,561,470
– – ﹤0.01% 4023
2022
Q4 		$343K Sell
1,561,470
-544
-0% -$163 ﹤0.01% 4197
2022
Q3 		$564K Buy
1,562,014
+457,450
+41% +$312K ﹤0.01% 4182
2022
Q2 		$718K Hold
1,104,564
– – ﹤0.01% 4191
2022
Q1 		$906K Sell
1,104,564
-301,221
-21% -$281K ﹤0.01% 4238
2021
Q4 		$1.6M Buy
1,405,785
+508,091
+57% +$1.03M ﹤0.01% 4120
2021
Q3 		$2.25M Buy
897,694
+42,449
+5% +$118K ﹤0.01% 4030
2021
Q2 		$2.54M Sell
855,245
-64,063
-7% -$223K ﹤0.01% 3901
2021
Q1 		$3.23M Sell
919,308
-118,975
-11% -$662K ﹤0.01% 3733
2020
Q4 		$4.93M Sell
1,038,283
-267,285
-20% -$1.38M ﹤0.01% 3362
2020
Q3 		$6.34M Buy
1,305,568
+208,360
+19% +$987K ﹤0.01% 3027
2020
Q2 		$3.57M Buy
1,097,208
+414,152
+61% +$3.93M ﹤0.01% 3243
2020
Q1 		$3.5M Buy
683,056
+4,995
+0.7% +$20.2K ﹤0.01% 3122
2019
Q4 		$3.09M Hold
678,061
– – ﹤0.01% 3326
2019
Q3 		$4.15M Buy
678,061
+8,229
+1% +$49K ﹤0.01% 3202
2019
Q2 		$4.08M Hold
669,832
– – ﹤0.01% 3239
2019
Q1 		$3.72M Buy
669,832
+10,023
+2% +$65.1K ﹤0.01% 3244
2018
Q4 		$3.73M Buy
659,809
+130,205
+25% +$960K ﹤0.01% 3187
2018
Q3 		$5.56M Buy
529,604
+8,450
+2% +$90.7K ﹤0.01% 3195
2018
Q2 		$5.79M Sell
521,154
-1,471
-0.3% -$13.2K ﹤0.01% 3160
2018
Q1 		$4.18M Buy
522,625
+158,971
+44% +$1.27M ﹤0.01% 3217
2017
Q4 		$2.98M Sell
363,654
-2,100
-0.6% -$14.2K ﹤0.01% 3306
2017
Q3 		$2.27M Buy
365,754
+10,957
+3% +$67.4K ﹤0.01% 3361
2017
Q2 		$2.15M Hold
354,797
– – ﹤0.01% 3354
2017
Q1 		$1.88M Buy
354,797
+100
+0% +$582 ﹤0.01% 3400
2016
Q4 		$2.41M Buy
354,697
+3,759
+1% +$26K ﹤0.01% 3302
2016
Q3 		$2.59M Buy
350,938
+196,548
+127% +$1.42M ﹤0.01% 3297
2016
Q2 		$1.26M Buy
154,390
+5,749
+4% +$44.8K ﹤0.01% 3538
2016
Q1 		$891K Buy
148,641
+2,400
+2% +$12.4K ﹤0.01% 3630
2015
Q4 		$779K Buy
146,241
+600
+0.4% +$3.01K ﹤0.01% 3697
2015
Q3 		$589K Buy
145,641
+2,397
+2% +$10.8K ﹤0.01% 3806
2015
Q2 		$703K Hold
143,244
– – ﹤0.01% 3763
2015
Q1 		$567K Buy
143,244
+1,700
+1% +$6.69K ﹤0.01% 3797
2014
Q4 		$557K Buy
141,544
+1,500
+1% +$6.21K ﹤0.01% 3696
2014
Q3 		$521K Hold
140,044
– – ﹤0.01% 3699
2014
Q2 		$480K Hold
140,044
– – ﹤0.01% 3693
2014
Q1 		$480K Buy
140,044
+1,900
+1% +$6.67K ﹤0.01% 3662
2013
Q4 		$466K Hold
138,144
– – ﹤0.01% 3617
2013
Q3 		$503K Buy
138,144
+113,558
+462% +$482K ﹤0.01% 3547
2013
Q2 		$123K Buy
+24,586
New +$114K ﹤0.01% 3709

Other funds holding CEMI

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Group's CEMI Position: Q2 2023 in Review

Vanguard Group sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2023, closing a stake of 1,561,470 shares — an estimated $690K sold.

Vanguard Group first reported a position in CEMI in Q2 2013 and held it in 40 quarters. The position peaked at $6.34M in Q3 2020. 1 fund tracked by Wall St. Rank holds CEMI as of Q2 2023.

  • Vanguard Group reported no remaining Chembio diagnostics, Inc. position as of Q2 2023 after selling out during the quarter.
  • Vanguard Group sold 1,561,470 Chembio diagnostics, Inc. shares in Q2 2023, an estimated $690K.
  • Vanguard Group first reported a position in Chembio diagnostics, Inc. in Q2 2013 and held it in 40 quarters.
  • Vanguard Group's Chembio diagnostics, Inc. position peaked at $6.34M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2023.

Based on Vanguard Group's 13F filing for Q2 2023, filed 14 Aug 2023.